{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-006891","form_type":"8-K","ticker":"BIXT","cik":"0001445815","company_name":"BIOXYTRAN, INC","filed_at":"2026-02-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.100814+00:00","generated_at":"2026-05-16T02:23:40.083455+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Bioxytran signs distribution deal with Khoury Medical for A-SUQAR supplement","bullets":["Agreement with Khoury Medical to commercialize A-SUQAR, a chewable blood sugar supplement using Bioxytran's PHGG formulation.","CEO David Platt says deal marks transition from development-stage to recurring commercial revenue while preserving IP ownership.","Volume-based marketplace exclusivity possible if defined purchase thresholds are met, per agreement terms.","Initial commercial shipments expected after completion of standard launch preparations; manufacturing by Bioxytran's OEM.","Bioxytran retains full IP; deal applies only to non-pharmaceutical dietary products, preserving pharma/antiviral programs."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-006891","json":"https://secwatch.observer/filing/0001493152-26-006891.json","markdown":"https://secwatch.observer/filing/0001493152-26-006891.md","text":"https://secwatch.observer/filing/0001493152-26-006891.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1445815/000149315226006891/0001493152-26-006891-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1445815/000149315226006891/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:23:40.083455+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dcaf99c7eb68130ee2acef3f890c087213bedab8","claim":"BIOXYTRAN, INC entered into Distribution Agreement with Khoury Medical LTD (effective 2026-02-10).","evidence_excerpt":"On February 10, 2026, Bioxytran entered into a commercial Distribution Agreement, attached hereto as Exhibit 10.90, with Khoury Medical LTD","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1445815/000149315226006891/0001493152-26-006891-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"supply"},{"label":"Counterparty","value":"Khoury Medical LTD"},{"label":"Effective","value":"2026-02-10"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}